DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Seino Y, Sasaki T, Fukatsu A. et al.
Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled, phase 3 study.
Curr Med Res Opin 2014;
30: 1245-1255
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.